Smiths Group (LON:SMIN)‘s stock had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co. in a research report issued on Monday. They presently have a GBX 1,800 ($24.87) price objective on the stock. JPMorgan Chase & Co.’s price target indicates a potential upside of 12.50% from the company’s current price.
Several other equities research analysts have also weighed in on the stock. Numis Securities raised shares of Smiths Group to an “add” rating and set a GBX 1,725 ($23.83) target price on the stock in a report on Friday, January 12th. Deutsche Bank reaffirmed a “buy” rating and issued a GBX 1,750 ($24.18) target price on shares of Smiths Group in a report on Monday, December 4th. Credit Suisse Group reaffirmed an “outperform” rating and issued a GBX 1,730 ($23.90) target price on shares of Smiths Group in a report on Friday, December 8th. Barclays initiated coverage on shares of Smiths Group in a report on Tuesday, February 13th. They issued an “overweight” rating and a GBX 1,800 ($24.87) target price on the stock. Finally, Jefferies Group reaffirmed a “hold” rating and issued a GBX 1,575 ($21.76) target price on shares of Smiths Group in a report on Thursday, February 22nd. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Smiths Group presently has an average rating of “Buy” and a consensus price target of GBX 1,753.50 ($24.23).
Smiths Group (LON:SMIN) traded down GBX 10 ($0.14) on Monday, hitting GBX 1,600 ($22.11). 927,906 shares of the stock traded hands, compared to its average volume of 1,190,000. Smiths Group has a fifty-two week low of GBX 1,442 ($19.92) and a fifty-two week high of GBX 1,697 ($23.45). The company has a market cap of $6,330.00 and a price-to-earnings ratio of 1,126.76.
ILLEGAL ACTIVITY WARNING: “Smiths Group (SMIN) Receives Overweight Rating from JPMorgan Chase & Co.” was published by American Banking News and is the property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/03/12/smiths-group-smin-receives-overweight-rating-from-jpmorgan-chase-co.html.
About Smiths Group
Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.
Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.